Abstract:As a powerful tool for genome-wide gene expression analysis, DNA microarray technology is widely used in biomedical research. One important application of microarrays is to identify differentially expressed genes (DEGs) between two distinct biological conditions, e.g. disease versus normal or treatment versus control, so that the underlying molecular mechanism differentiating the two conditions maybe revealed. Mechanistic interpretation of microarray results requires the identification of reproducible and reliable lists of DEGs, because irreproducible lists of DEGs may lead to different biological conclusions. Many vendors are providing microarray platforms of different characteristics for gene expression analysis, and the widely publicized apparent lack of intra- and cross-platform concordance in DEGs from microarray analysis of the same sets of study samples has been of great concerns to the scientific community and regulatory agencies like the US Food and Drug Administration (FDA). In this chapter, we describe the study design of and the main findings from the FDA-led MicroArray Quality Control (MAQC) project that aims to objectively assess the performance of different microarray platforms and the advantages and limitations of various competing statistical methods in identifying DEGs from microarray data. Using large data sets generated on two human reference RNA samples established by the MAQC project, we show that the levels of concordance in inter-laboratory and cross-platform comparisons are generally high. Furthermore, the levels of concordance largely depend on the statistical criteria used for ranking and selecting DEGs, irrespective of the chosen platforms or test sites. Importantly, a straightforward method combining fold-change ranking with a non-stringent P-value cutoff produces more reproducible lists of DEGs than those by t-test P-value ranking. Similar conclusions are reached when microarray data sets from a rat toxicogenomics study are analyzed. The availability of the MAQC reference RNA samples and the large reference data sets provides a unique resource for the gene expression community to reach consensus on the "best practices" for the generation, analysis, and applications of microarray data in drug development and personalized medicine.

ArrayTrack: an FDA and Public Genomic Tool

Development of Public Toxicogenomics Software for Microarray Data Management and Analysis

ArrayTrack--supporting Toxicogenomic Research at the U.S. Food and Drug Administration National Center for Toxicological Research.

An Integrated Bioinformatics Infrastructure Essential for Advancing Pharmacogenomics and Personalized Medicine in the Context of the FDA's Critical Path Initiative

SNPTrack™ : an integrated bioinformatics system for genetic association studies

QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies.

Technical Issues Involved in Obtaining Reliable Data from Microarray Experiments

The Microarray Quality Control (Maqc) Project And Cross-Platform Analysis Of Microarray Data

Towards the development of an omics data analysis framework

QA/QC Issues to Aid Regulatory Acceptance of Microarray Gene Expression Data

Application of DNA Microarray Technologies in Neurotoxicology Research

Public data and open source tools for multi-assay genomic investigation of disease

An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection

The NCATS BioPlanet – An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics

Reproducible and Reliable Microarray Results Through Quality Control: Good Laboratory Proficiency and Appropriate Data Analysis Practices Are Essential

Application of Microarray Technique in Toxicology

ToxDAR: A Workflow Software for Analyzing Toxicologically Relevant Proteomic and Transcriptomic Data, from Data Preparation to Toxicological Mechanism Elucidation

Human Transcriptome Array for High-Throughput Clinical Studies

In Pursuit of Effective Toxicogenomics

CellMinerCDB: NCATS is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations.